Tuesday, October 25, 2016

Zyprexa Zydis


See also: Generic Zyprexa, Generic Zyprexa Relprevv


Zyprexa Zydis is a brand name of olanzapine, approved by the FDA in the following formulation(s):


ZYPREXA ZYDIS (olanzapine - tablet, orally disintegrating; oral)



  • Manufacturer: LILLY

    Approval date: April 6, 2000

    Strength(s): 10MG [AB], 15MG [AB], 20MG [AB], 5MG [RLD][AB]

Has a generic version of Zyprexa Zydis been approved?


A generic version of Zyprexa Zydis has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Zyprexa Zydis and have been approved by the FDA:


olanzapine tablet, orally disintegrating; oral



  • Manufacturer: APOTEX INC

    Approval date: October 24, 2011

    Strength(s): 10MG [AB], 15MG [AB], 20MG [AB], 5MG [AB]


  • Manufacturer: BARR LABS INC

    Approval date: January 30, 2012

    Strength(s): 10MG [AB], 15MG [AB], 20MG [AB], 5MG [AB]


  • Manufacturer: DR REDDYS LABS LTD

    Approval date: October 24, 2011

    Strength(s): 10MG [AB], 15MG [AB], 20MG [AB], 5MG [AB]


  • Manufacturer: PAR PHARM

    Approval date: October 24, 2011

    Strength(s): 10MG [AB], 15MG [AB], 20MG [AB], 5MG [AB]


  • Manufacturer: TORRENT PHARMS LLC

    Approval date: October 25, 2011

    Strength(s): 10MG [AB], 15MG [AB], 20MG [AB], 5MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zyprexa Zydis. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • 2-methyl-thieno-benzodiazepine
    Patent 5,229,382
    Issued: July 20, 1993
    Inventor(s): Chakrabarti; Jiban K. & Hotten; Terrence M. & Tupper; David E.
    Assignee(s): Lilly Industries Limited
    2-Methyl-10-(4-methyl-1-piperazinyl)-4H-thieno-[2,3-b][1,5]benzodiazepine, or an acid salt thereof, has pharmaceutical properties, and is of particular use in the treatment of disorders of the central nervous system. The compound has the following structure: ##STR1##
    Patent expiration dates:

    • October 23, 2011
      ✓ 
      Pediatric exclusivity




  • Combination therapy for treatment of refractory depression
    Patent 6,960,577
    Issued: November 1, 2005
    Inventor(s): Tollefson; Gary Dennis
    Assignee(s): Eli Lilly and Company
    Methods for treating a patient suffering from or susceptible to treatment resistant major depression comprising administering olanzapine and fluoxetine are disclosed.
    Patent expiration dates:

    • November 1, 2017
      ✓ 
      Patent use: ZYPREXA ZYDIS AND FLUOXETINE IN COMBINATION FOR THE ACUTE TREATMENT OF TREATMENT RESISTANT DEPRESSION IN ADULTS



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • March 19, 2012 - TREATMENT OF TREATMENT RESISTANT DEPRESSION (TRD) IN COMBINATION WITH FLUOXETINE

    • December 4, 2012 - NEW PATIENT POPULATION

    • June 4, 2013 - PEDIATRIC EXCLUSIVITY

See also...

  • Zyprexa Zydis Orally Disintegrating Tablets Consumer Information (Wolters Kluwer)
  • Zyprexa Zydis Consumer Information (Cerner Multum)
  • Zyprexa Zydis Advanced Consumer Information (Micromedex)
  • Olanzapine Consumer Information (Wolters Kluwer)
  • Olanzapine Extended-Release Consumer Information (Wolters Kluwer)
  • Olanzapine Orally Disintegrating Tablets Consumer Information (Wolters Kluwer)
  • Olanzapine Tablets Consumer Information (Wolters Kluwer)
  • Olanzapine Consumer Information (Cerner Multum)
  • Olanzapine injection Consumer Information (Cerner Multum)
  • Olanzapine Advanced Consumer Information (Micromedex)
  • Olanzapine Intramuscular Advanced Consumer Information (Micromedex)
  • Olanzapine AHFS DI Monographs (ASHP)

No comments:

Post a Comment